Neuronetics, Inc. STIM
Set alert
At close · Oct 30
After hours · Oct 30, 7:44 PM ET
- YTD
- +63.04%
- 1 year
- -16.67%
- Open
- 2.34
- Prev close
- 2.38
- Mkt cap
- 171.44M
- Vol
- 1.09M
- Avg vol
- 1.62M
- EPS
- -0.43
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.15
- High
- 2.38
- Forward P/E
- -2.15
- Beta
- 2.22
- Short ratio
- 4.05
- Inst. own
- 53.32%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 12, 2024
- 50-d avg
- 1.02
- 200-d avg
- 1.94
- 1y target
- 2.67
News
1 week ago globenewswire.com
Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call
MALVERN, Pa., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through…
3 weeks ago defenseworld.net
Neuronetics, Inc. (NASDAQ:STIM) Stock Now Rated “Moderate Buy” by Sell-Side Brokerages
Shares of Neuronetics, Inc. (NASDAQ: STIM - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the five brokerages that are covering the stock, Marketbeat reports. One…
-
1 month ago benzinga.com
B. Riley Securities Initiates Coverage On Neuronetics with Buy Rating, Announces Price Target of $5
B. Riley Securities analyst Madison El-Saadi initiates coverage on Neuronetics (NASDAQ:STIM) with a Buy rating and announces Price Target of $5.
1 month ago globenewswire.com
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System
MALVERN, Pa., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health and provider of NeuroStar® TMS technology and direct patient care through…
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regular session. The market value of their outstanding shares is at $151.0 million. As per the press release,…
2 months ago seekingalpha.com
Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript
Neuronetics, Inc. (STIM) Q2 2026 Earnings Call Transcript
2 months ago marketbeat.com
Neuronetics Q2 Earnings Call Highlights
Neuronetics NASDAQ: STIM reported second-quarter 2026 revenue growth, a sharply narrower net loss and positive adjusted EBITDA as its Greenbrook clinic business expanded and the company introduced…
2 months ago zacks.com
Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates
Neuronetics (STIM) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.15 per share a year ago.
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Mereo BioPharma Group (NASDAQ:MREO) stock increased by 21.7% to $0.33 during Tuesday's pre-market session. The market value of their outstanding shares is at $43.4 million. Organigram Global…
-
2 months ago benzinga.com
Neuronetics Narrows FY2026 Sales Guidance from $160.000M-$166.000M to $160.000M-$164.000M vs $161.125M Est
Neuronetics (NASDAQ:STIM) narrows FY2026 sales outlook from $160.000 million-$166.000 million to $160.000 million-$164.000 million vs $161.125 million estimate.
-
2 months ago benzinga.com
Neuronetics Q2 EPS $(0.05) Beats $(0.13) Estimate, Sales $41.568M Beat $40.175M Estimate
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.13) by 58.33 percent. This is a 66.67 percent increase over losses of $(0.15)…
3 months ago globenewswire.com
Neuronetics and Jorey Chernett Announce Shared Vision
MALVERN, Pa., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics” or the “Company”) and Jorey Chernett, the Company's second largest shareholder and Managing Member of…
3 months ago globenewswire.com
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through…
3 months ago globenewswire.com
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland
New location expands access to advanced mental health treatments while serving as Greenbrook's flagship innovation center and blueprint for future care delivery New location expands access to…
3 months ago globenewswire.com
Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call
MALVERN, Pa., July 28, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through…
-
3 months ago benzinga.com
Neuronetics Appoints Nir Naor CFO, Effective July 23,
Neuronetics, Inc. (NASDAQ:STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional…
3 months ago globenewswire.com
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes
MALVERN, Pa., July 20, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through…
3 months ago benzinga.com
Why Is Neuronetics Stock Soaring Monday?
BTIG initiated coverage of Neuronetics Inc. (NASDAQ:STIM) on Monday, noting that the company is entering a pivotal new phase as the psilocybin opportunity takes center stage.
3 months ago benzinga.com
Why Is Neuronetics Stock Soaring Monday?
BTIG initiates coverage on Neuronetics (STIM) with a Buy rating and $5 target as shares surge 28%. Read the details here.
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 322.6% to $2.95 during Monday's regular session. The company's market cap stands at $33.0 million. Advanced Biomed (NASDAQ:ADVB) stock…
-
3 months ago benzinga.com
BTIG Initiates Coverage On Neuronetics with Buy Rating, Announces Price Target of $5
BTIG analyst Sam Eiber initiates coverage on Neuronetics (NASDAQ:STIM) with a Buy rating and announces Price Target of $5.
3 months ago seekingalpha.com
Neuronetics: Top Line Growth, Low Valuation, But Gross Margin Struggles
Neuronetics is revisited following prior coverage in March 2026. The article focuses on STIM's recent developments and their impact on the investment thesis. Key topics include operational progress,…
3 months ago globenewswire.com
Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026
MALVERN, Pa., July 06, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through…
5 months ago globenewswire.com
Neuronetics Appoints Robert Greene as Senior Vice President Sales
MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of…
5 months ago globenewswire.com
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026
MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of…
-
5 months ago benzinga.com
Neuronetics Collaborates With ANT Neuro To Expand NeuroStar Advanced Therapy System
Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth…
5 months ago globenewswire.com
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment
MALVERN, Pa., May 14, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life…
6 months ago seekingalpha.com
Neuronetics, Inc. (STIM) Q1 2026 Earnings Call Transcript
Neuronetics, Inc. (STIM) Q1 2026 Earnings Call Transcript
6 months ago zacks.com
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates
Neuronetics (STIM) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.21 per share a year ago.
-
6 months ago benzinga.com
Full Transcript: Neuronetics Q1 2026 Earnings Call
Full Transcript: Neuronetics Q1 2026 Earnings Call
-
6 months ago benzinga.com
Neuronetics Affirms FY2026 Sales Guidance of $160.000M-$166.000M vs $162.467M Est
Business OutlookFor the second quarter of 2026, the Company expects total revenue growth in the mid-single digits.For the full year 2026, Neuronetics continues to expect:Total revenue between $160…
-
6 months ago benzinga.com
Neuronetics Q1 EPS $(0.16) Beats $(0.17) Estimate, Sales $34.454M Beat $34.183M Estimate
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.17) by 5.88 percent. This is a 23.81 percent increase over losses of $(0.21)…
6 months ago globenewswire.com
Neuronetics Reports First Quarter 2026 Financial and Operating Results
MALVERN, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”), a vertically integrated, commercial stage, medical technology and healthcare company…
6 months ago benzinga.com
Deal Dispatch: Unilever Buys Grüns, Pershing Square Eyes Universal Music Group, Saks Global Reorganization Plan
This week's deal activity spans gaming, healthcare, energy, and private equity, with activist sales pushes and a slew of bankruptcies.
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
-
6 months ago benzinga.com
Neuronetics Initiates Workforce Reduction Impacting Up To 5% Of Employees, Expects ~$200K Restructuring Charges And ~$2.5-$3M Annualized Savings
On April 2, 2026, the Company initiated a workforce reduction, which it expects to be completed by mid-year 2026, that will impact up to 5% of its employees. The reduction is part of a broader effort…
-
6 months ago benzinga.com
Neuronetics CFO Steven E. Pfanstiel To Depart, Effective May 1; Reiterates Q1, FY26 Outlook
Neuronetics, Inc. (NASDAQ:STIM) (the "Company"), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from…
-
7 months ago benzinga.com
Canaccord Genuity Maintains Buy on Neuronetics, Lowers Price Target to $3
Canaccord Genuity analyst William Plovanic maintains Neuronetics (NASDAQ:STIM) with a Buy and lowers the price target from $7 to $3.
-
7 months ago benzinga.com
Neuronetics Sees FY2026 Sales $160.000M-$166.000M vs $164.167M Est
Neuronetics (NASDAQ:STIM) sees FY2026 sales of $160.000 million-$166.000 million vs $164.167 million analyst estimate.
-
7 months ago benzinga.com
Neuronetics Q4 EPS $(0.10) Beats $(0.11) Estimate, Sales $41.777M Beat $40.667M Estimate
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 6.54 percent. This is a 70.59 percent increase over losses of $(0.34)…
-
7 months ago benzinga.com
Earnings Scheduled For March 17, 2026
Earnings Scheduled For March 17, 2026
-
8 months ago benzinga.com
Peering Into Neuronetics Inc's Recent Short Interest
Peering Into Neuronetics Inc's Recent Short Interest
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
8 months ago benzinga.com
Why Teradata Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Why Teradata Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
8 months ago benzinga.com
Neuronetics (STIM) Stock Rises 41% After Hours: What's Going On?
Neuronetics shares jumped 41% in after-hours trading following strong preliminary fourth-quarter 2025 revenue results.
-
8 months ago benzinga.com
Neuronetics Reports Q4 Preliminary Revenue $41.8M, FY25 Revenue $149.2M
Neuronetics, Inc., (NASDAQ:STIM) (the "Company" or "Neuronetics") a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the…
11 months ago benzinga.com
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November
-
12 months ago benzinga.com
Neuronetics Lowers FY2025 Sales Guidance from $149.000M-$155.000M to $147.000M-$150.000M vs $151.030M Est
Neuronetics (NASDAQ:STIM) lowers FY2025 sales outlook from $149.000 million-$155.000 million to $147.000 million-$150.000 million vs $151.030 million estimate.